Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02696083 · ClinicalTrials.gov registry record · NA
Proof of Concept Study of PEMF (Pulsed Electromagnetic Field) Therapy in Subjects With Osteoarthritis of the Knee
A NA study, sponsored by Regenesis Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02696083 is a NA study that has completed, run by Regenesis Biomedical. The registered enrollment target is 19 participants.
The verdict
NCT02696083, a NA study, has completed, sponsored by Regenesis Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
To investigate the effect of PEMF treatment when administered twice daily over a 90-day period by looking at synovial fluid in subjects with osteoarthritis of the knee.
Interventions
- DEVICE Provant Therapy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-02-02 |
| Est. Completion | 2016-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02696083
The ClinicalTrials.gov registry entry for NCT02696083 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Regenesis Biomedical, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Provant Therapy System is the first listed.
NCT02696083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02696083 about?
NCT02696083 is a clinical study titled "Proof of Concept Study of PEMF (Pulsed Electromagnetic Field) Therapy in Subjects With Osteoarthritis of the Knee". To investigate the effect of PEMF treatment when administered twice daily over a 90-day period by looking at synovial fluid in subjects with osteoarthritis of the knee.
What is the current status of trial NCT02696083?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2016-02-02. Estimated completion is 2016-09-23.
What interventions are being tested in trial NCT02696083?
The interventions under investigation include: Provant Therapy System (DEVICE).
Who is sponsoring clinical trial NCT02696083?
This trial is sponsored by Regenesis Biomedical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.